Skip to main content
. 2016 Jun 23;5:212296. doi: 10.7573/dic.212296

Table 6.

Log-rank tests of time to TKR among different HA cohorts.

Log-rank test
Index therapy Chi-square p value
Euflexxa compared with Supartz/Hyalgan 1.013 0.3142
Synvisc compared with Supartz/Hyalgan 14.914 0.0001*
Orthovisc compared with Supartz/Hyalgan 2.274 0.1315
*

Statistically significant at alpha level of 0.05.